Medalogix Announces Doctors’ Choice Home Health as Newest Client

stock_medalogix

The home health agency will use Medalogix’s analytics-based population health management tool, Touch, to help reduce hospital readmissions

Medalogix, a leading home health and hospice analytics company, today announced its newest partner in care, Doctors’ Choice Home Health, a certified Medicare and ACHC accredited home health agency serving Northeast Florida.

Doctors’ Choice is deploying Medalogix’s analytics-based population health management solution, Touch, which helps home health providers increase touch points with the most at-risk patients to avoid unnecessary readmissions and drive referrals. In a peer-reviewed study, the technology solution proves to reduce readmission by a relative rate of more than 20 percent.

“Medalogix is a wonderful analytics and workflow solution that allows us to focus on increasing touch points with patients who are at risk for readmission,” said Kathy Edwards RN, director of operations at Doctors’ Choice Home Health.

“We’re proud to work with Doctors’ Choice in their charge to leverage technology to reduce hospital readmissions and improve patient care,” said Dan Hogan, CEO of Medalogix. “They’re a progressive team dedicated to providing the best in home health care.

Medalogix currently offers two home health solutions: Medalogix Touch and Bridge. Touch is a population health management technology that identifies patients who are at the greatest risk of transferring off home health census and those who would benefit from an additional care episode. After identifying the relevant patients, Touch equips providers with an automated calling component that schedules appropriate follow up calls and a watchlist module that helps monitor high-risk patients nearing the end of their episodes.

Bridge identifies patients who could benefit from hospice care and then equips providers with organizational workflows to ensure the right patients hear about their end of life options at the right time. The solution is especially useful for dual home health and hospice providers, adding predictive insights and operational efficiency to their hospice transition process.

The Bridge solution was recently recognized by Harvard University as an impactful healthcare innovation when Medalogix was selected from a pool of 500 applicants as a finalist in its Health Acceleration Challenge.